Appelbaum F R

Top coauthors of Appelbaum F R

Storb R (183 papers)

Buckner C D (119 papers)

Deeg H J (93 papers)

Sanders J E (62 papers)

Bensinger W I (61 papers)

List of Appelbaum F R publications

2016

Wood W A, McGinn M K, Wilson D, Deal A M, Khera N, et al. 2016. "Practice Patterns and Preferences among Hematopoietic Cell Transplantation Clinicians." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation doi:10.1016/j.bbmt.2016.07.014
Othus M, Wood B L, Stirewalt D L, Estey E H, Petersdorf S H, et al. 2016. "Effect of measurable ("minimal") residual disease (MRD) information on prediction of relapse and survival in adult acute myeloid leukemia." Leukemia doi:10.1038/leu.2016.120
Zhou Y, Othus M, Araki D, Wood B L, Radich J P, et al. 2016. "Pre- and post-transplant quantification of measurable ('minimal') residual disease via multiparameter flow cytometry in adult acute myeloid leukemia." Leukemia doi:10.1038/leu.2016.46

2015

Walter R B, Othus M, Burnett A K, Löwenberg B, Kantarjian H M, et al. 2015. "Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center." Leukemia 29 (2) doi:10.1038/leu.2014.242
Huang J C, Basu S K, Zhao X, Chien S, Fang M, et al. 2015. "Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration." Blood cancer journal 5 doi:10.1038/bcj.2015.17
Walter R B, Gyurkocza B, Storer B E, Godwin C D, Pagel J M, et al. 2015. "Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation." Leukemia 29 (1) doi:10.1038/leu.2014.173

2014

Walter R B, Laszlo G S, Lionberger J M, Pollard J A, Harrington K H, et al. 2014. "Heterogeneity of clonal expansion and maturation-linked mutation acquisition in hematopoietic progenitors in human acute myeloid leukemia." Leukemia 28 (10) doi:10.1038/leu.2014.107
Castilla-Llorente C, Martin P J, McDonald G B, Storer B E, Appelbaum F R, et al. 2014. "Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation." Bone marrow transplantation 49 (7) doi:10.1038/bmt.2014.69

2013

Othus M, Kantarjian H, Petersdorf S, Ravandi F, Godwin J, et al. 2013. "Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson." Leukemia doi:10.1038/leu.2013.176
Buckley S A, Appelbaum F R, Walter R B 2013. "Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia." Bone marrow transplantation 48 (5) doi:10.1038/bmt.2012.139

2010

Walter R B, Pagel J M, Gooley T A, Petersdorf E W, Sorror M L, et al. 2010. "Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission." Leukemia 24 (7) doi:10.1038/leu.2010.102
Ho P A, Alonzo T A, Kopecky K J, Miller K L, Kuhn J, et al. 2010. "Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study." Leukemia 24 (5) doi:10.1038/leu.2010.56
Sanders J E, Hoffmeister P A, Storer B E, Appelbaum F R, Storb R F, Syrjala K L 2010. "The quality of life of adult survivors of childhood hematopoietic cell transplant." Bone marrow transplantation 45 (4) doi:10.1038/bmt.2009.224

2009

Furlong T, Martin P, Flowers M E D, Carnevale-Schianca F, Yatscoff R, et al. 2009. "Therapy with mycophenolate mofetil for refractory acute and chronic GVHD." Bone marrow transplantation 44 (11) doi:10.1038/bmt.2009.76
McCune J S, Batchelder A, Guthrie K A, Witherspoon R, Appelbaum F R, et al. 2009. "Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy." Clinical pharmacology and therapeutics 85 (6) doi:10.1038/clpt.2009.27

2005

Hussein M A, Gundacker H, Head D R, Elias L, Foon K A, et al. 2005. "Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706." Leukemia 19 (11) doi:10.1038/sj.leu.2403940

2004

Appelbaum F R 2004. "Bone marrow transplantation for leukaemia--current status and strategies for improvement." Annals of the Academy of Medicine, Singapore 33 (5 Suppl) doi:
Yusuf U, Frangoul H A, Gooley T A, Woolfrey A E, Carpenter P A, et al. 2004. "Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience." Bone marrow transplantation 33 (8) doi:10.1038/sj.bmt.1704438

2003

Benesch M, McDonald G B, Schubert M, Appelbaum F R, Deeg H J 2003. "Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study." Bone marrow transplantation 32 (11) doi:10.1038/sj.bmt.1704277
Chen Chien-Shing, Boeckh M, Seidel K, Clark J G, Kansu E, et al. 2003. "Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation." Bone marrow transplantation 32 (5) doi:10.1038/sj.bmt.1704162
Stirewalt D L, Appelbaum F R, Willman C L, Zager R A, Banker D E 2003. "Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression." Leukemia research 27 (2) doi:

2002

Larson R A, Boogaerts M, Estey E, Karanes C, Stadtmauer E A, et al. 2002. "Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)." Leukemia 16 (9) doi:10.1038/sj.leu.2402677
McCune J S, Gooley T, Gibbs J P, Sanders J E, Petersdorf E W, et al. 2002. "Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation." Bone marrow transplantation 30 (3) doi:10.1038/sj.bmt.1703612
Pagel J M, Matthews D C, Appelbaum F R, Bernstein I D, Press O W 2002. "The use of radioimmunoconjugates in stem cell transplantation." Bone marrow transplantation 29 (10) doi:10.1038/sj.bmt.1703524
Doney K C, Chauncey T, Appelbaum F R 2002. "Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia." Bone marrow transplantation 29 (10) doi:10.1038/sj.bmt.1703548

2001

Benito A I, Furlong T, Martin P J, Anasetti C, Appelbaum F R, et al. 2001. "Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease." Transplantation 72 (12) doi:
Storek J, Joseph A, Espino G, Dawson M A, Douek D C, et al. 2001. "Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation." Blood 98 (13) doi:
Kansu E, Gooley T, Flowers M E, Anasetti C, Deeg H J, et al. 2001. "Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial." Blood 98 (13) doi:
List A F, Kopecky K J, Willman C L, Head D R, Persons D L, et al. 2001. "Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study." Blood 98 (12) doi:
Radich J P, Gooley T, Bryant E, Chauncey T, Clift R, et al. 2001. "The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation." Blood 98 (6) doi:
Gutierrez-Delgado F, Maloney D G, Press O W, Golden J, Holmberg L A, et al. 2001. "Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens." Bone marrow transplantation 28 (5) doi:10.1038/sj.bmt.1703179
Linenberger M L, Hong T, Flowers D, Sievers E L, Gooley T A, et al. 2001. "Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin." Blood 98 (4) doi:
Morrison V A, Rai K R, Peterson B L, Kolitz J E, Elias L, et al. 2001. "Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19 (16) doi:
Anderson J E, Tefferi A, Craig F, Holmberg L, Chauncey T, et al. 2001. "Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis." Blood 98 (3) doi:
Sievers E L, Larson R A, Stadtmauer E A, Estey E, Löwenberg B, et al. 2001. "Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19 (13) doi:
Appelbaum F R 2001. "Perspectives on the future of chronic myeloid leukemia treatment." Seminars in hematology 38 (3 Suppl 8) doi:
Storek J, Dawson M A, Storer B, Stevens-Ayers T, Maloney D G, et al. 2001. "Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation." Blood 97 (11) doi:
McSweeney P A, Niederwieser D, Shizuru J A, Sandmaier B M, Molina A J, et al. 2001. "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects." Blood 97 (11) doi:
Stirewalt D L, Kopecky K J, Meshinchi S, Appelbaum F R, Slovak M L, et al. 2001. "FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia." Blood 97 (11) doi:
Appelbaum F R 2001. "Haematopoietic cell transplantation as immunotherapy." Nature 411 (6835) doi:10.1038/35077251
Al-Ghamdi H, Leisenring W, Bensinger W I, Nash R A, Storb R, et al. 2001. "A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest." British journal of haematology 113 (2) doi:
Rowley S D, Donaldson G, Lilleby K, Bensinger W I, Appelbaum F R 2001. "Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation." Blood 97 (9) doi:
Witherspoon R P, Deeg H J, Storer B, Anasetti C, Storb R, Appelbaum F R 2001. "Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19 (8) doi:
Garrido S M, Appelbaum F R, Willman C L, Banker D E 2001. "Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)." Experimental hematology 29 (4) doi:
Gopal A K, Gooley T A, Golden J B, Maloney D G, Bensinger W I, et al. 2001. "Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older." Bone marrow transplantation 27 (6) doi:10.1038/sj.bmt.1702833
Petersdorf S H, Kopecky K J, Head D R, Boldt D H, Balcerzak S P, et al. 2001. "Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study." Leukemia 15 (2) doi:
Bensinger W I, Martin P J, Storer B, Clift R, Forman S J, et al. 2001. "Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers." The New England journal of medicine 344 (3) doi:10.1056/NEJM200101183440303
Bennett C L, Hynes D, Godwin J, Stinson T J, Golub R M, Appelbaum F R 2001. "Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial." Cancer investigation 19 (6) doi:
Appelbaum F R, Rowe J M, Radich J, Dick J E 2001. "Acute myeloid leukemia." Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program doi:
Storb R, Blume K G, O'Donnell M R, Chauncey T, Forman S J, et al. 2001. "Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 7 (1) doi:10.1053/bbmt.2001.v7.pm11215697
Garrido S M, Cooper J J, Appelbaum F R, Willman C L, Kopecky K, Banker D E 2001. "Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis." Leukemia research 25 (1) doi:
Anderson J E, Appelbaum F R, Schoch G, Barnett T, Chauncey T R, et al. 2001. "Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 7 (3) doi:10.1053/bbmt.2001.v7.pm11302550

2000

Slovak M L, Kopecky K J, Cassileth P A, Harrington D H, Theil K S, et al. 2000. "Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study." Blood 96 (13) doi:
Rai K R, Peterson B L, Appelbaum F R, Kolitz J, Elias L, et al. 2000. "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia." The New England journal of medicine 343 (24) doi:10.1056/NEJM200012143432402
Koc S, Leisenring W, Flowers M E, Anasetti C, Deeg H J, et al. 2000. "Thalidomide for treatment of patients with chronic graft-versus-host disease." Blood 96 (12) doi:
Furlong T, Storb R, Anasetti C, Appelbaum F R, Deeg H J, et al. 2000. "Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities." Bone marrow transplantation 26 (9) doi:10.1038/sj.bmt.1702639
Press O W, Eary J F, Gooley T, Gopal A K, Liu S, et al. 2000. "A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas." Blood 96 (9) doi:
Koc S, Hagglund H, Ireton R C, Perez-Simon J A, Collins S J, Appelbaum F R 2000. "Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation." Bone marrow transplantation 26 (8) doi:10.1038/sj.bmt.1702611
Sierra J, Storer B, Hansen J A, Martin P J, Petersdorf E W, et al. 2000. "Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience." Bone marrow transplantation 26 (4) doi:10.1038/sj.bmt.1702519
Deeg H J, Appelbaum F R 2000. "Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome." Leukemia research 24 (8) doi:
Gutierrez-Delgado F, Holmberg L A, Hooper H, Appelbaum F R, Livingston R B, et al. 2000. "High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer." Bone marrow transplantation 26 (1) doi:10.1038/sj.bmt.1702461
Zhang F F, Murata-Collins J L, Gaytan P, Forman S J, Kopecky K J, et al. 2000. "Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia." Genes, chromosomes & cancer 28 (3) doi:
Chauncey T R, Rankin C, Anderson J E, Chen I, Kopecky K J, et al. 2000. "A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617." Leukemia research 24 (7) doi:
Garrido S M, Bryant E, Appelbaum F R 2000. "Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities." Leukemia research 24 (6) doi:
Crump C, Chen C, Appelbaum F R, Kopecky K J, Schwartz S M, et al. 2000. "Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 9 (5) doi:
Garrido S M, Willman C, Appelbaum F R, Banker D E 2000. "Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples." Cytometry 42 (2) doi:
Deeg H J, Appelbaum F R 2000. "Hemopoietic stem cell transplantation for myelodysplastic syndrome." Current opinion in oncology 12 (2) doi:
Rosen P J, Rankin C, Head D R, Boldt D H, Luthardt F W, et al. 2000. "A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia." Leukemia research 24 (3) doi:
Appelbaum F R 2000. "Is there a best transplant conditioning regimen for acute myeloid leukemia?" Leukemia 14 (3) doi:
Deeg H J, Shulman H M, Anderson J E, Bryant E M, Gooley T A, et al. 2000. "Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age." Blood 95 (4) doi:
Radich J P, Gooley T, Sanders J E, Anasetti C, Chauncey T, Appelbaum F R 2000. "Second allogeneic transplantation after failure of first autologous transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 6 (3) doi:
Flowers M E, Leisenring W, Beach K, Riddell S, Radich J P, et al. 2000. "Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 6 (3A) doi:
Nash R A, Kurzrock R, DiPersio J, Vose J, Linker C, et al. 2000. "A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 6 (1) doi:
Tallman M S, Andersen J W, Schiffer C A, Appelbaum F R, Feusner J H, et al. 2000. "Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome." Blood 95 (1) doi:
Cavallaro A M, Lilleby K, Majolino I, Storb R, Appelbaum F R, et al. 2000. "Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor." Bone marrow transplantation 25 (1) doi:10.1038/sj.bmt.1702072

1999

Holmberg L A, Boeckh M, Hooper H, Leisenring W, Rowley S, et al. 1999. "Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation." Blood 94 (12) doi:
Appelbaum F R 1999. "Antibody-targeted therapy for myeloid leukemia." Seminars in hematology 36 (4 Suppl 6) doi:
Appelbaum F R 1999. "Molecular diagnosis and clinical decisions in adult acute leukemia." Seminars in hematology 36 (4) doi:
Martin P J, Rowley S D, Anasetti C, Chauncey T R, Gooley T, et al. 1999. "A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients." Blood 94 (7) doi:
Silver R T, Woolf S H, Hehlmann R, Appelbaum F R, Anderson J, et al. 1999. "An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology." Blood 94 (5) doi:
Karanes C, Kopecky K J, Head D R, Grever M R, Hynes H E, et al. 1999. "A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study." Leukemia research 23 (9) doi:
Matthews D C, Appelbaum F R, Eary J F, Fisher D R, Durack L D, et al. 1999. "Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome." Blood 94 (4) doi:
Leith C P, Kopecky K J, Chen I M, Eijdems L, Slovak M L, et al. 1999. "Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study." Blood 94 (3) doi:
Stirewalt D L, Clurman B, Appelbaum F R, Willman C L, Radich J P 1999. "p73 mutations and expression in adult de novo acute myelogenous leukemia." Leukemia 13 (7) doi:
Gibbs J P, Gooley T, Corneau B, Murray G, Stewart P, et al. 1999. "The impact of obesity and disease on busulfan oral clearance in adults." Blood 93 (12) doi:
Sievers E L, Appelbaum F R, Spielberger R T, Forman S J, Flowers D, et al. 1999. "Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate." Blood 93 (11) doi:
Li Q, Kopecky K J, Mohan A, Willman C L, Appelbaum F R, et al. 1999. "Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia." Clinical cancer research : an official journal of the American Association for Cancer Research 5 (5) doi:
Matthews D C, Martin P J, Nourigat C, Appelbaum F R, Fisher D R, Bernstein I D 1999. "Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models." Blood 93 (2) doi:
Storb R, Raff R F, Graham T, Appelbaum F R, Deeg H J, et al. 1999. "Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 5 (3) doi:10.1053/bbmt.1999.v5.pm10392961

1998

Cassileth P A, Harrington D P, Appelbaum F R, Lazarus H M, Rowe J M, et al. 1998. "Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission." The New England journal of medicine 339 (23) doi:10.1056/NEJM199812033392301
Banker D E, Radich J, Becker A, Kerkof K, Norwood T, et al. 1998. "The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults." Clinical cancer research : an official journal of the American Association for Cancer Research 4 (12) doi:
Woolfrey A E, Gooley T A, Sievers E L, Milner L A, Andrews R G, et al. 1998. "Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome." Blood 92 (10) doi:
Holmberg L A, Demirer T, Rowley S, Buckner C D, Goodman G, et al. 1998. "High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer." Bone marrow transplantation 22 (7) doi:10.1038/sj.bmt.1701398
Liu S Y, Eary J F, Petersdorf S H, Martin P J, Maloney D G, et al. 1998. "Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 16 (10) doi:
Appelbaum F R, Anderson J 1998. "Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score." Leukemia 12 Suppl 1 doi:
Ren S, Kalhorn T F, McDonald G B, Anasetti C, Appelbaum F R, Slattery J T 1998. "Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients." Clinical pharmacology and therapeutics 64 (3) doi:10.1016/S0009-9236(98)90178-3
Morton A J, Gooley T, Hansen J A, Appelbaum F R, Bruemmer B, et al. 1998. "Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase." Blood 92 (2) doi:
Sullivan K M, Anasetti C, Horowitz M, Rowlings P A, Petersdorf E W, et al. 1998. "Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry." Annals of the New York Academy of Sciences 850 doi:
Godwin J E, Kopecky K J, Head D R, Willman C L, Leith C P, et al. 1998. "A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031)." Blood 91 (10) doi:
Sandmaier B M, Storb R, Bennett K L, Appelbaum F R, Santos E B 1998. "Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model." Blood 91 (9) doi:
Storb R, Raff R, Deeg H J, Graham T, Appelbaum F R, et al. 1998. "Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts." International journal of radiation oncology, biology, physics 40 (4) doi:
Banker D E, Groudine M, Willman C L, Norwood T, Appelbaum F R 1998. "Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents." Leukemia research 22 (3) doi:
Sullivan K M, Kansu E, Storer B, Jocom J, Emerson G, et al. 1998. "Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 4 (1) doi:

1997

Storek J, Gooley T, Siadak M, Bensinger W I, Maloney D G, et al. 1997. "Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease." Blood 90 (12) doi:
Appelbaum F R, Kopecky K J 1997. "Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group." Cancer 80 (11 Suppl) doi:
Chen C S, Seidel K, Armitage J O, Fay J W, Appelbaum F R, et al. 1997. "Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 3 (6) doi:
Schuening F G, von Kalle C, Kiem H P, Appelbaum F R, Deeg H J, et al. 1997. "Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs." Experimental hematology 25 (12) doi:
Schiffman K, Buckner C D, Maziarz R, Maloney D G, Appelbaum F R, et al. 1997. "High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 3 (5) doi:
Tallman M S, Andersen J W, Schiffer C A, Appelbaum F R, Feusner J H, et al. 1997. "All-trans-retinoic acid in acute promyelocytic leukemia." The New England journal of medicine 337 (15) doi:10.1056/NEJM199710093371501
Storb R, Leisenring W, Anasetti C, Appelbaum F R, Deeg H J, et al. 1997. "Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?" Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 3 (4) doi:
Anderson J E, Sale G, Appelbaum F R, Chauncey T R, Storb R 1997. "Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis." British journal of haematology 98 (4) doi:
Sierra J, Radich J, Hansen J A, Martin P J, Petersdorf E W, et al. 1997. "Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia." Blood 90 (4) doi:
Gallagher R E, Willman C L, Slack J L, Andersen J W, Li Y P, et al. 1997. "Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study." Blood 90 (4) doi:
Anderson J E, Appelbaum F R 1997. "Myelodysplasia and myeloproliferative disorders." Current opinion in hematology 4 (4) doi:
Bensinger W I, Schiffman K S, Holmberg L, Appelbaum F R, Maziarz R, et al. 1997. "High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer." Bone marrow transplantation 19 (12) doi:10.1038/sj.bmt.1700820
Sierra J, Storer B, Hansen J A, Bjerke J W, Martin P J, et al. 1997. "Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose." Blood 89 (11) doi:
Deeg H J, Lin D, Leisenring W, Boeckh M, Anasetti C, et al. 1997. "Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial." Blood 89 (10) doi:
Appelbaum F R 1997. "Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)." Leukemia 11 Suppl 4 doi:
Appelbaum F R 1997. "Allogeneic stem cell transplantation for the treatment of hematologic malignancies: current indications and challenges." The Journal of rheumatology. Supplement 48 doi:
Leith C P, Kopecky K J, Godwin J, McConnell T, Slovak M L, et al. 1997. "Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study." Blood 89 (9) doi:
Slattery J T, Clift R A, Buckner C D, Radich J, Storer B, et al. 1997. "Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation." Blood 89 (8) doi:
Anderson J E, Gooley T A, Schoch G, Anasetti C, Bensinger W I, et al. 1997. "Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy." Blood 89 (7) doi:
Radich J, Gehly G, Lee A, Avery R, Bryant E, et al. 1997. "Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation." Blood 89 (7) doi:
Robinson N, Benyunes M C, Thompson J A, York A, Petersdorf S, et al. 1997. "Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study." Bone marrow transplantation 19 (5) doi:10.1038/sj.bmt.1700687
Demirer T, Buckner C D, Storer B, Lilleby K, Rowley S, et al. 1997. "Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 15 (2) doi:
Appelbaum F R 1997. "Allogeneic hematopoietic stem cell transplantation for acute leukemia." Seminars in oncology 24 (1) doi:
Doney K, Leisenring W, Storb R, Appelbaum F R 1997. "Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team." Annals of internal medicine 126 (2) doi:
Banker D E, Groudine M, Norwood T, Appelbaum F R 1997. "Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia." Blood 89 (1) doi:

1996

Bensinger W I, Buckner C D, Shannon-Dorcy K, Rowley S, Appelbaum F R, et al. 1996. "Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy." Blood 88 (11) doi:
Tsai T, Davalath S, Rankin C, Radich J P, Head D, et al. 1996. "Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies." Leukemia 10 (12) doi:
Corcoran M C, Press O W, Matthews D C, Appelbaum F R, Bernstein I D 1996. "The role of radioimmunotherapy in bone marrow transplantation." Current opinion in hematology 3 (6) doi:
Weick J K, Kopecky K J, Appelbaum F R, Head D R, Kingsbury L L, et al. 1996. "A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study." Blood 88 (8) doi:
Huss R, Deeg H J, Gooley T, Bryant E, Leisenring W, et al. 1996. "Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia." Bone marrow transplantation 18 (4) doi:
Bensinger W I, Buckner C D, Anasetti C, Clift R, Storb R, et al. 1996. "Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome." Blood 88 (7) doi:
Bensinger W I, Clift R, Martin P, Appelbaum F R, Demirer T, et al. 1996. "Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation." Blood 88 (7) doi:
McSweeney P A, Rouleau K A, Storb R, Bolles L, Wallace P M, et al. 1996. "Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein." Blood 88 (6) doi:
Bensinger W I, Demirer T, Buckner C D, Appelbaum F R, Storb R, et al. 1996. "Syngeneic marrow transplantation in patients with multiple myeloma." Bone marrow transplantation 18 (3) doi:
Martin P J, Nelson B J, Appelbaum F R, Anasetti C, Deeg H J, et al. 1996. "Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation." Blood 88 (3) doi:
Demirer T, Petersen F B, Bensinger W I, Appelbaum F R, Fefer A, et al. 1996. "Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia." Bone marrow transplantation 18 (1) doi:
Brunvand M W, Bensinger W I, Soll E, Weaver C H, Rowley S D, et al. 1996. "High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells." Bone marrow transplantation 18 (1) doi:
Demirer T, Buckner C D, Gooley T, Appelbaum F R, Rowley S, et al. 1996. "Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma." Bone marrow transplantation 17 (6) doi:
Schiffman K S, Bensinger W I, Appelbaum F R, Rowley S, Lilleby K, et al. 1996. "Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease." Bone marrow transplantation 17 (6) doi:
Press O W, Shan D, Howell-Clark J, Eary J, Appelbaum F R, et al. 1996. "Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells." Cancer research 56 (9) doi:
Bensinger W I, Rowley S D, Demirer T, Lilleby K, Schiffman K, et al. 1996. "High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (5) doi:
Slattery J T, Kalhorn T F, McDonald G B, Lambert K, Buckner C D, et al. 1996. "Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (5) doi:
Demirer T, Buckner C D, Appelbaum F R, Clift R, Storb R, et al. 1996. "High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer." Bone marrow transplantation 17 (5) doi:
Walters M C, Patience M, Leisenring W, Eckman J R, Buchanan G R, et al. 1996. "Barriers to bone marrow transplantation for sickle cell anemia." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2 (2) doi:
Kiem H P, McDonald G B, Myerson D, Spurgeon C L, Deeg H J, et al. 1996. "Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2 (2) doi:
Anderson J E, Anasetti C, Appelbaum F R, Schoch G, Gooley T A, et al. 1996. "Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia." British journal of haematology 93 (1) doi:
Sanders J E, Hawley J, Levy W, Gooley T, Buckner C D, et al. 1996. "Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation." Blood 87 (7) doi:
Demirer T, Buckner C D, Appelbaum F R, Bensinger W I, Sanders J, et al. 1996. "Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels." Bone marrow transplantation 17 (4) doi:
Demirer T, Buckner C D, Appelbaum F R, Lambert K, Bensinger W I, et al. 1996. "Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels." Bone marrow transplantation 17 (3) doi:
Robinson N, Sanders J E, Benyunes M C, Beach K, Lindgren C, et al. 1996. "Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia." Blood 87 (4) doi:
Vose J M, Anderson J E, Bierman P J, Appelbaum F R, Anderson J R, et al. 1996. "Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (2) doi:
Sullivan K M, Storek J, Kopecky K J, Jocom J, Longton G, et al. 1996. "A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2 (1) doi:
Appelbaum F R 1996. "The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer." CA: a cancer journal for clinicians 46 (3) doi:
Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, et al. 1996. "Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (1) doi:
Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, et al. 1996. "Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors." Blood 87 (1) doi:
Nash R A, Gooley T, Davis C, Appelbaum F R 1996. "The problem of thrombocytopenia after hematopoietic stem cell transplantation." Stem cells (Dayton, Ohio) 14 Suppl 1 doi:10.1002/stem.140743

1995

Soll E, Massumoto C, Clift R A, Buckner C D, Appelbaum F R, et al. 1995. "Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment." Blood 86 (12) doi:
Balduzzi A, Gooley T, Anasetti C, Sanders J E, Martin P J, et al. 1995. "Unrelated donor marrow transplantation in children." Blood 86 (8) doi:
Leith C P, Chen I M, Kopecky K J, Appelbaum F R, Head D R, et al. 1995. "Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases." Blood 86 (6) doi:
Meyskens F L, Kopecky K J, Appelbaum F R, Balcerzak S P, Samlowski W, Hynes H 1995. "Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial." Leukemia research 19 (9) doi:
Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift R A, et al. 1995. "A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia." Blood 86 (5) doi:
Nash R A, Burstein S A, Storb R, Yang W, Abrams K, et al. 1995. "Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets." Blood 86 (5) doi:
Press O W, Eary J F, Appelbaum F R, Martin P J, Nelp W B, et al. 1995. "Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas." Lancet 346 (8971) doi:
Appelbaum F R, Clift R, Radich J, Anasetti C, Buckner C D 1995. "Bone marrow transplantation for chronic myelogenous leukemia." Seminars in oncology 22 (4) doi:
Demirer T, Petersen F B, Appelbaum F R, Barnett T A, Sanders J, et al. 1995. "Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial." International journal of radiation oncology, biology, physics 32 (4) doi:
Slattery J T, Sanders J E, Buckner C D, Schaffer R L, Lambert K W, et al. 1995. "Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics." Bone marrow transplantation 16 (1) doi:
Demirer T, Rowley S, Buckner C D, Appelbaum F R, Lilleby K, et al. 1995. "Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 13 (7) doi:
Appelbaum F R 1995. "Allogeneic marrow transplantation and the use of hematopoietic growth factors." Stem cells (Dayton, Ohio) 13 (4) doi:10.1002/stem.5530130404
Welborn J L, Kopecky K J, Meyers F J, Veith R, Shurafa M, et al. 1995. "Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial." Leukemia 9 (7) doi:
Nash R A, Etzioni R, Storb R, Furlong T, Gooley T, et al. 1995. "Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study." Blood 85 (12) doi:
Demirer T, Gooley T, Buckner C D, Petersen F B, Lilleby K, et al. 1995. "Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation." Bone marrow transplantation 15 (6) doi:
Demirer T, Buckner C D, Appelbaum F R, Petersen F B, Rowley S, et al. 1995. "Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia." Bone marrow transplantation 15 (6) doi:
Slovak M L, Kopecky K J, Wolman S R, Henslee-Downey J P, Appelbaum F R, et al. 1995. "Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612)." Leukemia research 19 (6) doi:
Slovak M L, Traweek S T, Willman C L, Head D R, Kopecky K J, et al. 1995. "Trisomy 11: an association with stem/progenitor cell immunophenotype." British journal of haematology 90 (2) doi:
Nash R A, Seidel K, Storb R, Slichter S, Schuening F G, et al. 1995. "Effects of rhIL-11 on normal dogs and after sublethal radiation." Experimental hematology 23 (5) doi:
Bigelow C L, Kopecky K, Files J C, Head D, Lipschitz D A, et al. 1995. "Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: a Southwest Oncology Group study." American journal of hematology 48 (4) doi:
Bensinger W I, Weaver C H, Appelbaum F R, Rowley S, Demirer T, et al. 1995. "Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor." Blood 85 (6) doi:
Deeg H J, Seidel K, Bruemmer B, Pepe M S, Appelbaum F R 1995. "Impact of patient weight on non-relapse mortality after marrow transplantation." Bone marrow transplantation 15 (3) doi:
Anderson J E, Appelbaum F R, Storb R 1995. "An update on allogeneic marrow transplantation for myelodysplastic syndrome." Leukemia & lymphoma 17 (1-2) doi:10.3109/10428199509051708
Matthews D C, Appelbaum F R, Eary J F, Fisher D R, Durack L D, et al. 1995. "Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation." Blood 85 (4) doi:
Langenmayer I, Weaver C, Buckner C D, Lilleby K, Appelbaum F R, et al. 1995. "Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both." Bone marrow transplantation 15 (2) doi:
Andrews R G, Briddell R A, Knitter G H, Rowley S D, Appelbaum F R, McNiece I K 1995. "Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates." Blood 85 (1) doi:
Lynch M H, Petersen F B, Appelbaum F R, Bensinger W I, Clift R A, et al. 1995. "Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies." Bone marrow transplantation 15 (1) doi:

1994

Boldt D H, Kopecky K J, Head D, Gehly G, Radich J P, Appelbaum F R 1994. "Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience." Leukemia 8 (12) doi:
Weaver C H, Clift R A, Deeg H J, Storb R, Appelbaum F R, et al. 1994. "Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia." Bone marrow transplantation 14 (6) doi:
Weaver C H, Petersen F B, Appelbaum F R, Bensinger W I, Press O, et al. 1994. "High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 12 (12) doi:
Storb R, Raff R F, Appelbaum F R, Deeg H J, Graham T C, et al. 1994. "DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors." Blood 84 (10) doi:
Weaver C H, Bensinger W I, Appelbaum F R, Lilleby K, Sandmaier B, et al. 1994. "Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies." Bone marrow transplantation 14 (5) doi:
Silberman G, Crosse M G, Peterson E A, Weston R C, Horowitz M M, et al. 1994. "Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries." The New England journal of medicine 331 (16) doi:10.1056/NEJM199410203311606
Nemunaitis J, Ross M, Meisenberg B, O'Reilly R, Lilleby K, et al. 1994. "Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure." Bone marrow transplantation 14 (4) doi:
Anasetti C, Hansen J A, Waldmann T A, Appelbaum F R, Davis J, et al. 1994. "Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor." Blood 84 (4) doi:
Andrews R G, Briddell R A, Knitter G H, Opie T, Bronsden M, et al. 1994. "In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells." Blood 84 (3) doi:
Storb R, Etzioni R, Anasetti C, Appelbaum F R, Buckner C D, et al. 1994. "Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia." Blood 84 (3) doi:
Demirer T, Buckner C D, Lilleby K, Weaver C, Longin K, et al. 1994. "Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease." Cancer 74 (2) doi:
Scott A A, Head D R, Kopecky K J, Appelbaum F R, Theil K S, et al. 1994. "HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3." Blood 84 (1) doi:
Eary J F, Pollard K R, Durack L D, Bice A N, Lewellen T K, et al. 1994. "Post therapy imaging in high dose I-131 radioimmunotherapy patients." Medical physics 21 (7) doi:
Luce B R, Singer J W, Weschler J M, Buckner C D, Sheingold S H, et al. 1994. "Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial." PharmacoEconomics 6 (1) doi:
de Revel T, Appelbaum F R, Storb R, Schuening F, Nash R, et al. 1994. "Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs." Blood 83 (12) doi:
Nemunaitis J, Appelbaum F R, Lilleby K, Buhles W C, Rosenfeld C, et al. 1994. "Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia." Blood 83 (12) doi:
Storb R, Raff R F, Appelbaum F R, Deeg H J, Graham T C, et al. 1994. "Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts." Blood 83 (11) doi:
Busca A, Anasetti C, Anderson G, Appelbaum F R, Buckner C D, et al. 1994. "Unrelated donor or autologous marrow transplantation for treatment of acute leukemia." Blood 83 (10) doi:
Andrews R G, Briddell R A, Appelbaum F R, McNiece I K 1994. "Stimulation of hematopoiesis in vivo by stem cell factor." Current opinion in hematology 1 (3) doi:
Anderson J E, Appelbaum F R 1994. "Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321." Current opinion in hematology 1 (3) doi:
Deeg H J, Beckham C, Huss R, Myerson D, Greinix H, et al. 1994. "Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand." Blood 83 (8) doi:
Nash R A, Schuening F G, Seidel K, Appelbaum F R, Boone T, et al. 1994. "Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation." Blood 83 (7) doi:
Kiem H P, Darovsky B, von Kalle C, Goehle S, Stewart D, et al. 1994. "Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells." Blood 83 (6) doi:
Schwarzinger I, Raff R F, Flowers M, Niederwieser D, Graham T, et al. 1994. "Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow." Bone marrow transplantation 13 (3) doi:
Bean M A, Graham T, Appelbaum F R, Deeg H J, Schuening F, et al. 1994. "Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts." Transplantation 57 (3) doi:
Head D R, Kopecky K J, Willman C, Appelbaum F R 1994. "Treatment outcome with chemotherapy in acute promyelocytic leukemia: the Southwest Oncology Group (SWOG) experience." Leukemia 8 Suppl 2 doi:
Schuening F G, Nemunaitis J, Appelbaum F R, Storb R 1994. "Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials." Bone marrow transplantation 14 Suppl 4 doi:
Bearman S I, Mori M, Beatty P G, Meyer W G, Buckner C D, et al. 1994. "Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors." Bone marrow transplantation 13 (1) doi:
Saez R, Dahlberg S, Appelbaum F R, Hartsock R J, Lemaistre F, et al. 1994. "Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study." Hematological oncology 12 (2) doi:

1993

Anderson J E, Litzow M R, Appelbaum F R, Schoch G, Fisher L D, et al. 1993. "Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11 (12) doi:
Appelbaum F R 1993. "The use of colony stimulating factors in marrow transplantation." Cancer 72 (11 Suppl) doi:
Nemunaitis J, Appelbaum F R, Singer J W, Lilleby K, Wolff S, et al. 1993. "Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation." Blood 82 (11) doi:
Collins C, Eary J F, Donaldson G, Vernon C, Bush N E, et al. 1993. "Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial." Journal of nuclear medicine : official publication, Society of Nuclear Medicine 34 (11) doi:
Press O W, Eary J F, Appelbaum F R, Martin P J, Badger C C, et al. 1993. "Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support." The New England journal of medicine 329 (17) doi:10.1056/NEJM199310213291702
Storb R, Raff R F, Appelbaum F R, Deeg H J, Fitzsimmons W, et al. 1993. "FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors." Transplantation 56 (4) doi:
Weaver C H, Buckner C D, Longin K, Appelbaum F R, Rowley S, et al. 1993. "Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor." Blood 82 (7) doi:
Doney K, Buckner C D, Fisher L, Petersen F B, Sanders J, et al. 1993. "Autologous bone marrow transplantation for acute lymphoblastic leukemia." Bone marrow transplantation 12 (4) doi:
Clift R A, Bianco J A, Appelbaum F R, Buckner C D, Singer J W, et al. 1993. "A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation." Blood 82 (7) doi:
Nemunaitis J, Shannon-Dorcy K, Appelbaum F R, Meyers J, Owens A, et al. 1993. "Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor." Blood 82 (5) doi:
Doney K, Storb R, Appelbaum F R, Buckner C D, Sanders J, et al. 1993. "Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia." British journal of haematology 85 (1) doi:
Appelbaum F R 1993. "The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation." Seminars in oncology 20 (4 Suppl 4) doi:
Anderson J E, Appelbaum F R, Fisher L D, Schoch G, Shulman H, et al. 1993. "Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome." Blood 82 (2) doi:
Weaver C H, Appelbaum F R, Petersen F B, Clift R, Singer J, et al. 1993. "High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11 (7) doi:
Petersen F B, Lynch M H, Clift R A, Appelbaum F R, Sanders J E, et al. 1993. "Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11 (7) doi:
Raff R F, Severns E M, Storb R, Graham T C, Sale G, et al. 1993. "Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation." Transplantation 55 (6) doi:
Storb R, Raff R F, Graham T, Appelbaum F R, Deeg H J, et al. 1993. "Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model." International journal of radiation oncology, biology, physics 26 (2) doi:
Blume K G, Kopecky K J, Henslee-Downey J P, Forman S J, Stiff P J, et al. 1993. "A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group study." Blood 81 (8) doi:
Bensinger W I, Price T H, Dale D C, Appelbaum F R, Clift R, et al. 1993. "The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis." Blood 81 (7) doi:
Elias L, Stock-Novack D, Head D R, Grever M R, Weick J K, et al. 1993. "A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study." Leukemia 7 (3) doi:
Pene R, Appelbaum F R, Fisher L, Lilleby K, Nemunaitis J, et al. 1993. "Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation." Bone marrow transplantation 11 (3) doi:
Schiffman K, Clift R, Appelbaum F R, Sanders J, Bensinger W, et al. 1993. "Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia." Bone marrow transplantation 11 (3) doi:
Schuening F G, Appelbaum F R, Deeg H J, Sullivan-Pepe M, Graham T C, et al. 1993. "Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation." Blood 81 (1) doi:

1992

Andrews R G, Bensinger W I, Knitter G H, Bartelmez S H, Longin K, et al. 1992. "The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons." Blood 80 (11) doi:
Clift R A, Buckner C D, Appelbaum F R, Schoch G, Petersen F B, et al. 1992. "Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 10 (11) doi:
Raff R F, Storb R, Graham T, Fidler J M, Sale G E, et al. 1992. "Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone." Transplantation 54 (5) doi:
Appelbaum F R, Matthews D C, Eary J F, Badger C C, Kellogg M, et al. 1992. "The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia." Transplantation 54 (5) doi:
Anasetti C, Martin P J, Storb R, Appelbaum F R, Beatty P G, et al. 1992. "Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody." Transplantation 54 (5) doi:
Nash R A, Pepe M S, Storb R, Longton G, Pettinger M, et al. 1992. "Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate." Blood 80 (7) doi:
Appelbaum F R, Brown P A, Sandmaier B M, Storb R, Fisher D R, et al. 1992. "Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP." Blood 80 (6) doi:
Bensinger W I, Buckner C D, Clift R A, Petersen F B, Bianco J A, et al. 1992. "Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 10 (9) doi:
Andrews R G, Bartelmez S H, Knitter G H, Myerson D, Bernstein I D, et al. 1992. "A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons." Blood 80 (4) doi:
Petersen F B, Buckner C D, Appelbaum F R, Sanders J E, Bensinger W I, et al. 1992. "Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study." Bone marrow transplantation 10 (1) doi:
Doney K, Pepe M, Storb R, Bryant E, Anasetti C, et al. 1992. "Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone." Blood 79 (10) doi:
Flowers M E, Doney K C, Storb R, Deeg H J, Sanders J E, et al. 1992. "Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience." Bone marrow transplantation 9 (3) doi:
Matthews D C, Badger C C, Fisher D R, Hui T E, Nourigat C, et al. 1992. "Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody." Cancer research 52 (5) doi:
Petersen F B, Deeg H J, Buckner C D, Appelbaum F R, Storb R, et al. 1992. "Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial." International journal of radiation oncology, biology, physics 23 (5) doi:
Appelbaum F R, Badger C C, Bernstein I D, Buckner C D, Deeg H J, et al. 1992. "Is there a better way to deliver total body irradiation?" Bone marrow transplantation 10 Suppl 1 doi:
van der Jagt R H, Badger C C, Appelbaum F R, Press O W, Matthews D C, et al. 1992. "Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model." Cancer research 52 (1) doi:

1991

Bean M A, Storb R, Graham T, Raff R, Sale G E, et al. 1991. "Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood." Transplantation 52 (6) doi:
Schuening F G, Kawahara K, Miller A D, To R, Goehle S, et al. 1991. "Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs." Blood 78 (10) doi:
Badger C C, Davis J, Nourigat C, Wu Z M, Hui T E, et al. 1991. "Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I." Cancer research 51 (21) doi:
Andrews R G, Knitter G H, Bartelmez S H, Langley K E, Farrar D, et al. 1991. "Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates." Blood 78 (8) doi:
Greinix H T, Ladiges W C, Graham T C, Maslan S, Raff R F, et al. 1991. "Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody." Blood 78 (8) doi:
Appelbaum F R 1991. "Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma." Hematology/oncology clinics of North America 5 (5) doi:
Matthews D C, Appelbaum F R, Eary J F, Hui T E, Fisher D R, et al. 1991. "Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque." Blood 78 (7) doi:
Bianco J A, Appelbaum F R, Nemunaitis J, Almgren J, Andrews F, et al. 1991. "Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation." Blood 78 (5) doi:
Van der Jagt R H, Appelbaum F R, Petersen F B, Bigelow C L, Fisher L D, et al. 1991. "Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy." Bone marrow transplantation 8 (3) doi:
Doney K, Fisher L D, Appelbaum F R, Buckner C D, Storb R, et al. 1991. "Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival." Bone marrow transplantation 7 (6) doi:
Nemunaitis J, Buckner C D, Appelbaum F R, Higano C S, Mori M, et al. 1991. "Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation." Blood 77 (9) doi:
Anasetti C, Martin P J, Storb R, Appelbaum F R, Beatty P G, et al. 1991. "Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3." Bone marrow transplantation 7 (5) doi:
Saikevych I A, Kerrigan D P, McConnell T S, Head D R, Appelbaum F R, Willman C L 1991. "Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology." Leukemia 5 (5) doi:
Clift R A, Buckner C D, Appelbaum F R, Bryant E, Bearman S I, et al. 1991. "Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens." Blood 77 (8) doi:
Martin P J, Schoch G, Fisher L, Byers V, Appelbaum F R, et al. 1991. "A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment." Blood 77 (8) doi:
Sandmaier B M, Schuening F G, Bianco J A, Rosenman S J, Bernstein I, et al. 1991. "Biochemical characterization of a unique canine myeloid antigen." Leukemia 5 (2) doi:
Nemunaitis J, Singer J W, Buckner C D, Mori T, Laponi J, et al. 1991. "Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy." Bone marrow transplantation 7 (1) doi:

1990

Clift R A, Buckner C D, Appelbaum F R, Bearman S I, Petersen F B, et al. 1990. "Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens." Blood 76 (9) doi:
Loughran T P, Raff R F, Graham T C, Appelbaum F R, Schuening F G, et al. 1990. "Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts." Experimental hematology 18 (10) doi:
Martin P J, Schoch G, Fisher L, Byers V, Anasetti C, et al. 1990. "A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment." Blood 76 (8) doi:
Storb R, Pepe M, Anasetti C, Appelbaum F R, Beatty P, et al. 1990. "What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?" Blood 76 (5) doi:
Sandmaier B M, Storb R, Appelbaum F R, Gallatin W M 1990. "An antibody that facilitates hematopoietic engraftment recognizes CD44." Blood 76 (3) doi:
Schuening F G, Storb R, Goehle S, Graham T C, Hackman R, et al. 1990. "Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs." Blood 76 (3) doi:
Appelbaum F R 1990. "Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseases." Seminars in hematology 27 (3 Suppl 4) doi:
Nemunaitis J, Singer J W, Buckner C D, Durnam D, Epstein C, et al. 1990. "Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation." Blood 76 (1) doi:
Anasetti C, Martin P J, Hansen J A, Appelbaum F R, Beatty P G, et al. 1990. "A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease." Transplantation 50 (1) doi:
Appelbaum F R, Barrall J, Storb R, Fisher L D, Schoch G, et al. 1990. "Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome." Annals of internal medicine 112 (8) doi:
Petersen F B, Appelbaum F R, Hill R, Fisher L D, Bigelow C L, et al. 1990. "Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 8 (4) doi:
Bearman S I, Petersen F B, Schor R A, Denney J D, Fisher L D, et al. 1990. "Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity." Bone marrow transplantation 5 (3) doi:
Bernstein I D, Eary J F, Badger C C, Press O W, Appelbaum F R, et al. 1990. "High dose radiolabeled antibody therapy of lymphoma." Cancer research 50 (3 Suppl) doi:
Ladiges W C, Storb R, Raff R F, Appelbaum F R, Sandmaier B, et al. 1990. "Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients." Bone marrow transplantation 5 (1) doi:
Bigelow C L, Adler L T, Appelbaum F R 1990. "Impact of RLA matching and cyclosporine on long-term survival in transplanted rabbits." Experimental hematology 18 (1) doi:
Sullivan K M, Meyers J, Petersen F B, Bowden R, Counts G C, et al. 1990. "Supportive care of the marrow transplant recipient: the Seattle Experience." Haematology and blood transfusion 33 doi:
Appelbaum F R 1990. "Bone marrow transplantation for acute nonlymphocytic leukemia (ANL)." Cancer treatment and research 50 doi:

1989

Deeg H J, Graham T C, Gerhard-Miller L, Appelbaum F R, Schuening F, Storb R 1989. "Prevention of transfusion-induced graft-versus-host disease in dogs by ultraviolet irradiation." Blood 74 (7) doi:
Petersen F B, Buckner C D, Appelbaum F R, Clift R A, Sanders J E, et al. 1989. "Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study." Bone marrow transplantation 4 (6) doi:
Schuening F G, Storb R, Goehle S, Graham T C, Appelbaum F R, et al. 1989. "Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation." Blood 74 (4) doi:
Schuening F G, Storb R, Goehle S, Nash R, Graham T C, et al. 1989. "Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor." Experimental hematology 17 (8) doi:
Petersen F B, Appelbaum F R, Bigelow C L, Buckner C D, Clift R A, et al. 1989. "High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma." Bone marrow transplantation 4 (5) doi:
Bearman S I, Appelbaum F R, Back A, Petersen F B, Buckner C D, et al. 1989. "Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 7 (9) doi:
Storb R, Raff R F, Appelbaum F R, Graham T C, Schuening F G, et al. 1989. "Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts." Blood 74 (3) doi:
Press O W, Eary J F, Badger C C, Martin P J, Appelbaum F R, et al. 1989. "Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 7 (8) doi:
Appelbaum F R 1989. "The clinical use of hematopoietic growth factors." Seminars in hematology 26 (3 Suppl 3) doi:
Appelbaum F R, Raff R F, Storb R, Deeg H J, Graham T C, et al. 1989. "Use of trimetrexate for the prevention of graft-versus-host disease." Bone marrow transplantation 4 (4) doi:
Appelbaum F R, Brown P, Sandmaier B, Badger C, Schuening F, et al. 1989. "Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation." Blood 73 (8) doi:
Sullivan K M, Weiden P L, Storb R, Witherspoon R P, Fefer A, et al. 1989. "Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia." Blood 73 (6) doi:
Sullivan K M, Storb R, Buckner C D, Fefer A, Fisher L, et al. 1989. "Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms." The New England journal of medicine 320 (13) doi:10.1056/NEJM198903303201303
Tallman M S, Kopecky K J, Amos D, Dahlberg S, Hewlett J S, et al. 1989. "Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 7 (3) doi:
Anasetti C, Amos D, Beatty P G, Appelbaum F R, Bensinger W, et al. 1989. "Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma." The New England journal of medicine 320 (4) doi:10.1056/NEJM198901263200401
Hill R S, Mazza P, Amos D, Buckner C D, Appelbaum F R, et al. 1989. "Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation." Bone marrow transplantation 4 (1) doi:
Mortimer J, Blinder M A, Schulman S, Appelbaum F R, Buckner C D, et al. 1989. "Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 7 (1) doi:
Buckner C D, Fefer A, Bensinger W I, Storb R, Durie B G, et al. 1989. "Marrow transplantation for malignant plasma cell disorders: summary of the Seattle experience." European journal of haematology. Supplementum 51 doi:

1988

Martin P J, Clift R A, Fisher L D, Buckner C D, Hansen J A, et al. 1988. "HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration." Blood 72 (6) doi:
Petersen F B, Appelbaum F R, Buckner C D, Sanders J E, Clift R A, et al. 1988. "Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy." Bone marrow transplantation 3 (6) doi:
Raff R F, Severns E, Storb R, Martin P, Graham T, et al. 1988. "L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment." Transplantation 46 (5) doi:
Storb R, Raff R F, Appelbaum F R, Schuening F W, Sandmaier B M, et al. 1988. "What radiation dose for DLA-identical canine marrow grafts?" Blood 72 (4) doi:
Bearman S I, Appelbaum F R, Buckner C D, Petersen F B, Fisher L D, et al. 1988. "Regimen-related toxicity in patients undergoing bone marrow transplantation." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 6 (10) doi:
Appelbaum F R 1988. "Intensive chemotherapy or chemoradiotherapy with autologous marrow support as treatment for patients with solid tumors." Hematology/oncology clinics of North America 2 (3) doi:
Appelbaum F R, Nemunaitis J 1988. "Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man." Behring Institute Mitteilungen (83) doi:
Sullivan K M, Witherspoon R P, Storb R, Weiden P, Flournoy N, et al. 1988. "Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation." Blood 72 (2) doi:
Sullivan K M, Witherspoon R P, Storb R, Deeg H J, Dahlberg S, et al. 1988. "Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease." Blood 72 (2) doi:
Nemunaitis J, Singer J W, Buckner C D, Hill R, Storb R, et al. 1988. "Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies." Blood 72 (2) doi:
Appelbaum F R, Fisher L D, Thomas E D 1988. "Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up." Blood 72 (1) doi:
Appelbaum F R 1988. "Marrow transplantation for hematologic malignancies: a brief review of current status and future prospects." Seminars in hematology 25 (3 Suppl 3) doi:
Sanders J E, Buckner C D, Amos D, Levy W, Appelbaum F R, et al. 1988. "Ovarian function following marrow transplantation for aplastic anemia or leukemia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 6 (5) doi:
Deeg H J, Aprile J, Storb R, Graham T C, Hackman R, et al. 1988. "Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients." Blood 71 (4) doi:
Riddell S, Appelbaum F R, Buckner C D, Stewart P, Clift R, et al. 1988. "High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 6 (4) doi:
Appelbaum F R, Meyers J D, Deeg H J, Graham T, Schuening F, Storb R 1988. "Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs." Antimicrobial agents and chemotherapy 32 (2) doi:

1987

Meyers J D, Flournoy N, Sanders J E, McGuffin R W, Newton B A, et al. 1987. "Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation." Annals of internal medicine 107 (6) doi:
Appelbaum F R, Barrall J, Storb R, Ramberg R, Doney K, et al. 1987. "Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia." Experimental hematology 15 (11) doi:
Doney K, Buckner C D, Kopecky K J, Sanders J E, Appelbaum F R, et al. 1987. "Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission." Bone marrow transplantation 2 (4) doi:
Tricot G J, Lauer R C, Appelbaum F R, Jansen J, Hoffman R 1987. "Management of the myelodysplastic syndromes." Seminars in oncology 14 (4) doi:
Schuening F, Storb R, Goehle S, Meyer J, Graham T C, et al. 1987. "Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation." Transplantation 44 (5) doi:
Sale G E, Rajantie J, Doney K, Appelbaum F R, Storb R, Thomas E D 1987. "Does histologic grading of inflammation in bone marrow predict the response of aplastic anaemia patients to antithymocyte globulin therapy?" British journal of haematology 67 (3) doi:
Clift R A, Buckner C D, Thomas E D, Kopecky K J, Appelbaum F R, et al. 1987. "The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation." Bone marrow transplantation 2 (3) doi:
Appelbaum F R 1987. "Marrow transplantation for malignant lymphoma." Bone marrow transplantation 2 (3) doi:
Deeg H J, Sale G E, Storb R, Graham T C, Schuening F, et al. 1987. "Engraftment of DLA-nonidentical bone marrow facilitated by recipient treatment with anti-class II monoclonal antibody and methotrexate." Transplantation 44 (3) doi:
Bigelow C L, Adler L T, Appelbaum F R 1987. "Allogeneic bone marrow transplantation in irradiated adult rabbits." Transplantation 44 (3) doi:
Appelbaum F R, Sullivan K M, Buckner C D, Clift R A, Deeg H J, et al. 1987. "Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 5 (9) doi:
Storb R, Weiden P L, Sullivan K M, Appelbaum F R, Beatty P, et al. 1987. "Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin." Blood 70 (1) doi:
Dulley F L, Kanfer E J, Appelbaum F R, Amos D, Hill R S, et al. 1987. "Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation." Transplantation 43 (6) doi:
Tallman M S, Appelbaum F R, Amos D, Goldberg R S, Livingston R B, et al. 1987. "Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 5 (6) doi:
Sargur M, Buckner C D, Appelbaum F R, Stewart P, Deeg H J, et al. 1987. "Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 5 (5) doi:
Kanfer E J, Buckner C D, Fefer A, Storb R, Appelbaum F R, et al. 1987. "Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation." Bone marrow transplantation 1 (4) doi:
Doney K, Storb R, Buckner C D, McGuffin R, Witherspoon R, et al. 1987. "Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens." Experimental hematology 15 (3) doi:
Shields A F, Porter B A, Churchley S, Olson D O, Appelbaum F R, Thomas E D 1987. "The detection of bone marrow involvement by lymphoma using magnetic resonance imaging." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 5 (2) doi:
Appelbaum F R, Storb R, Ramberg R E, Shulman H M, Buckner C D, et al. 1987. "Treatment of preleukemic syndromes with marrow transplantation." Blood 69 (1) doi:
Appelbaum F R, Badger C C, Deeg H J, Nelp W B, Storb R 1987. "Use of iodine-131-labeled anti-immune response-associated monoclonal antibody as preparative regimen prior to bone marrow transplantation: initial dosimetry." NCI monographs : a publication of the National Cancer Institute (3) doi:

1986

Deeg H J, Sullivan K M, Buckner C D, Storb R, Appelbaum F R, et al. 1986. "Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation." Bone marrow transplantation 1 (2) doi:
Deeg H J, Self S, Storb R, Doney K, Appelbaum F R, et al. 1986. "Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors." Blood 68 (6) doi:
Sanders J E, Pritchard S, Mahoney P, Amos D, Buckner C D, et al. 1986. "Growth and development following marrow transplantation for leukemia." Blood 68 (5) doi:
Pecego R, Hill R, Appelbaum F R, Amos D, Buckner C D, et al. 1986. "Interstitial pneumonitis following autologous bone marrow transplantation." Transplantation 42 (5) doi:
Bolger G B, Sullivan K M, Spence A M, Appelbaum F R, Johnston R, et al. 1986. "Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host disease." Neurology 36 (8) doi:
Appelbaum F R, Deeg H J, Storb R, Graham T C, Charrier K, Bensinger W 1986. "Cure of malignant lymphoma in dogs with peripheral blood stem cell transplantation." Transplantation 42 (1) doi:
Lensink D B, Barton A, Appelbaum F R, Hammond W P 1986. "Cyclic neutropenia as a premalignant manifestation of acute lymphoblastic leukemia." American journal of hematology 22 (1) doi:
Klingemann H G, Storb R, Sanders J, Deeg H J, Appelbaum F R, Thomas E D 1986. "Acute lymphoblastic leukaemia after bone marrow transplantation for aplastic anaemia." British journal of haematology 63 (1) doi:
Anasetti C, Doney K C, Storb R, Meyers J D, Farewell V T, et al. 1986. "Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients." Annals of internal medicine 104 (4) doi:
Klingemann H G, Storb R, Fefer A, Deeg H J, Appelbaum F R, et al. 1986. "Bone marrow transplantation in patients aged 45 years and older." Blood 67 (3) doi:
Hill R S, Petersen F B, Storb R, Appelbaum F R, Doney K, et al. 1986. "Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease." Blood 67 (3) doi:
Deeg H J, Aprile J, Graham T C, Appelbaum F R, Storb R 1986. "Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs." Blood 67 (2) doi:
Sanders J E, Whitehead J, Storb R, Buckner C D, Clift R A, et al. 1986. "Bone marrow transplantation experience for children with aplastic anemia." Pediatrics 77 (2) doi:
Thomas E D, Clift R A, Fefer A, Appelbaum F R, Beatty P, et al. 1986. "Marrow transplantation for the treatment of chronic myelogenous leukemia." Annals of internal medicine 104 (2) doi:
Sullivan K M, Appelbaum F R, Horning S J, Rosenberg S A, Thomas E D 1986. "Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation." International journal of cell cloning 4 Suppl 1 doi:10.1002/stem.5530040711

1985

Appelbaum F R, Sullivan K M, Thomas E D, Buckner C D, Clift R A, et al. 1985. "Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 3 (11) doi:
Jin N R, Hill R S, Petersen F B, Buckner C D, Stewart P S, et al. 1985. "Marrow harvesting for autologous marrow transplantation." Experimental hematology 13 (9) doi:
Martin P J, Hansen J A, Buckner C D, Sanders J E, Deeg H J, et al. 1985. "Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts." Blood 66 (3) doi:
Deeg H J, Appelbaum F R, Weiden P L, Hackman R C, Graham T C, Storb R C 1985. "Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation." American journal of veterinary research 46 (9) doi:
Storb R, Deeg H J, Thomas E D, Appelbaum F R, Buckner C D, et al. 1985. "Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease." Blood 66 (3) doi:
Sanders J E, Thomas E D, Buckner C D, Flournoy N, Stewart P S, et al. 1985. "Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update." Blood 66 (2) doi:
Deeg H J, Loughran T P, Storb R, Kennedy M S, Sullivan K M, et al. 1985. "Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone." Transplantation 40 (2) doi:
Deeg H J, Storb R, Thomas E D, Flournoy N, Kennedy M S, et al. 1985. "Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia." Blood 65 (6) doi:
Kennedy M S, Deeg H J, Storb R, Doney K, Sullivan K M, et al. 1985. "Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine." The American journal of medicine 78 (6 Pt 1) doi:
Appelbaum F R, Thomas E D 1985. "Treatment of acute leukemia in adults with chemoradiotherapy and bone marrow transplantation." Cancer 55 (9 Suppl) doi:
Appelbaum F R, Deeg H J, Storb R, Self S, Graham T C, et al. 1985. "Marrow transplant studies in dogs with malignant lymphoma." Transplantation 39 (5) doi:
Szer J, Deeg H J, Appelbaum F R, Storb R 1985. "Failure of autologous marrow reconstitution after cytolytic treatment of marrow with anti-Ia monoclonal antibody." Blood 65 (4) doi:
Appelbaum F R, Cheever M A, Fefer A, Storb R, Thomas E D 1985. "Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: evidence for two mechanisms of graft failure." Blood 65 (3) doi:
Irle C, Deeg H J, Buckner C D, Kennedy M, Clift R, et al. 1985. "Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine." Leukemia research 9 (10) doi:
Sanders J E, Flournoy N, Thomas E D, Buckner C D, Lum L G, et al. 1985. "Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease." Medical and pediatric oncology 13 (4) doi:

1984

Appelbaum F R, Dahlberg S, Thomas E D, Buckner C D, Cheever M A, et al. 1984. "Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison." Annals of internal medicine 101 (5) doi:
Buckner C D, Clift R A, Sanders J E, Stewart P, Bensinger W I, et al. 1984. "Marrow harvesting from normal donors." Blood 64 (3) doi:
Appelbaum F R, Storb R, Ramberg R E, Shulman H M, Buckner C D, et al. 1984. "Allogeneic marrow transplantation in the treatment of preleukemia." Annals of internal medicine 100 (5) doi:
Deeg H J, Storb R, Appelbaum F R, Kennedy M S, Graham T C, Thomas E D 1984. "Combined immunosuppression with cyclosporine and methotrexate in dogs given bone marrow grafts from DLA-haploidentical littermates." Transplantation 37 (1) doi:
Appelbaum F R, Sale G E, Storb R, Charrier K, Deeg H J, et al. 1984. "Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy." Hematological oncology 2 (2) doi:

1983

Storb R, Prentice R L, Thomas E D, Appelbaum F R, Deeg H J, et al. 1983. "Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia." British journal of haematology 55 (4) doi:
Stewart P, Buckner C D, Thomas E D, Bagley C, Bensinger W, et al. 1983. "Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung." Cancer treatment reports 67 (12) doi:
Sullivan K M, Neiman P E, Kadin M E, Dahlberg S, Farewell V T, et al. 1983. "Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients." Blood 62 (1) doi:
Appelbaum F R, Thomas E D 1983. "Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1 (7) doi:
Appelbaum F R, Clift R A, Buckner C D, Stewart P, Storb R, et al. 1983. "Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse." Blood 61 (5) doi:
Storb R, Prentice R L, Banaji M, Witherspoon R P, Sullivan K M, et al. 1983. "Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?" Blood 61 (4) doi:
Appelbaum F R, Thomas E D, Buckner C D, Clift R A, Deeg H J, et al. 1983. "Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation." Hematological oncology 1 (2) doi:
Appelbaum F R, Najfeld V, Singer J W 1983. "Chronic myelogenous leukemia. Prolonged survival with spontaneous decline in the frequency of Ph1-positive cells and subsequent development of mixed Ph1-positive and Ph1-negative blast crisis." Cancer 51 (1) doi:

1982

Kaplan H G, Appelbaum F R, Cheever M A, Greenberg P D, Wood T, Fefer A 1982. "Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine." Cancer treatment reports 66 (6) doi:
Fefer A, Cheever M A, Greenberg P D, Appelbaum F R, Boyd C N, et al. 1982. "Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins." The New England journal of medicine 306 (2) doi:10.1056/NEJM198201143060202

1981

Appelbaum F R, Fefer A, Cheever M A, Buckner C D, Greenberg P D, et al. 1981. "Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins." Blood 58 (3) doi:
Gottdiener J S, Appelbaum F R, Ferrans V J, Deisseroth A, Ziegler J 1981. "Cardiotoxicity associated with high-dose cyclophosphamide therapy." Archives of internal medicine 141 (6) doi:
Fefer A, Cheever M A, Thomas E D, Appelbaum F R, Buckner C D, et al. 1981. "Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins." Blood 57 (3) doi:

1980

Abrams R A, Glaubiger D, Appelbaum F R, Deisseroth A B 1980. "Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report." Blood 56 (3) doi:
Tosato G, Appelbaum F R, Trapani R J, Dowling R, Deisseroth A B 1980. "Use of in vitro assays in selection of compatible platelet donors." Transfusion 20 (1) doi:
Walker R I, French J E, Walden D A, MacVittie T J, Parker G A, et al. 1980. "Protection of dogs from lethal consequences of endotoxemia with plasma or leukocyte transfusions." Advances in shock research 4 doi:
Klein H G, Faltz L L, McIntosh C L, Appelbaum F R, Deisseroth A B, Holland P V 1980. "Surgical hypothermia in a patient with a cold agglutinin. Management by plasma exchange." Transfusion 20 (3) doi:

1979

Flaum M A, Cuneo R A, Appelbaum F R, Deisseroth A B, Engel W K, Gralnick H R 1979. "The hemostatic imbalance of plasma-exchange transfusion." Blood 54 (3) doi:
Appelbaum F R, Herzig G, Graw R G, Zeigler J L 1979. "Accelerated hemopoietic recovery following the infusion of cryopreserved autologous bone marrow in humans." Experimental hematology 7 Suppl 5 doi:
Ungerleider R S, Appelbaum F R, Trapani R J, Deisseroth A B 1979. "Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy." Transfusion 19 (1) doi:
Appelbaum F R 1979. "Hemopoietic reconstitution following autologous bone marrow and peripheral blood mononuclear cell infusions." Experimental hematology 7 Suppl 5 doi:

1978

Gratwohl A A, Appelbaum F R, Levine A S, Ziegler J L, Deisseroth A B 1978. "[Long-term, complete remission in non-Hodgkin's lymphoma following high-dosage combination therapy with or without autologous bone marrow transplantation]." Schweizerische medizinische Wochenschrift 108 (49) doi:
Appelbaum F R, Herzig G P, Ziegler J L, Graw R G, Levine A S, Deisseroth A B 1978. "Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma." Blood 52 (1) doi:
Appelbaum F R, Deisseroth A B, Graw R G, Herzig G P, Levine A S, et al. 1978. "Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse." Cancer 41 (3) doi:
Levine A S, Appelbaum F R, Graw R G, Magrath I T, Pizzo P A, et al. 1978. "Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma." Cancer treatment reports 62 (2) doi:

1977

Appelbaum F R, Norton L, Graw R G 1977. "Migration of transfused granulocytes in leukopenic dogs." Blood 49 (3) doi:
Appelbaum F R, Trapani R J, Graw R G 1977. "Consequences of prior alloimmunization during granulocyte transfusion." Transfusion 17 (5) doi: